Key Updates in Pharmacy Standards Highlight Health Equity and Patient-Centered Care

May 31, 2025 - 18:25

Gurjyot K. Doshi, MD, recently addressed significant updates to the medically integrated pharmacy (MIP) standards, emphasizing the importance of health equity and patient-centered care in the management of oral oncolytics. As the landscape of cancer treatment continues to evolve, these updates aim to ensure that patients receive comprehensive and equitable care tailored to their individual needs.

The revised standards seek to enhance integrated workflows within healthcare systems, promoting collaboration among healthcare professionals to improve patient outcomes. By focusing on health equity, the new guidelines encourage the identification and reduction of barriers that may prevent certain populations from accessing effective oral cancer therapies.

Furthermore, the emphasis on patient-centered care highlights the necessity of involving patients in their treatment decisions, ensuring that their preferences and values are respected throughout the therapeutic process. This holistic approach aims to foster a more inclusive healthcare environment, ultimately leading to better management of oral oncolytic therapies and improved quality of life for patients battling cancer.